Content your physician signs, published to the site you already have. No setup fee, month to month →
Authoritize.ai
Back to Atlas
CRITICALGLP-1 / Weight Loss

RonanRx, Inc. dba RonanRx

FDA issued a warning letter to RonanRx, Inc. dba RonanRx (Elgin, TX) for false or misleading marketing of compounded semaglutide and tirzepatide products on its website and the social media platform X (formerly Twitter). The violations include falsely implying FDA approval of compounded drugs, misrepresenting products as 'American made' and 'farm-to-table drugs' when the active pharmaceutical ingredients have no FDA-registered U.S. manufacturer on record, and labeling products with 'RonanRx' as the compounder when it is not. FDA found these representations cause the products to be misbranded under FD&C Act sections 502(a) and 502(bb), and warned that failure to correct violations may result in seizure or injunction.

Well-Studied Compounded Medications

FDA-Approved Compounded Medications

Yea, seventy-eight dollars a month, for drugs like Ozempic. But are our drugs even legit? No. Our drugs are super [bleep] legit.

Compounded medications with substantial human clinical evidence—randomized trials, mechanistic studies, and decades of use—though the specific compounded preparation may not itself be FDA-approved.

Explore GLP-1s like Ozempic

American made

Compounded medications whose active ingredient has at least one FDA-approved branded form for the indication described.

farm-to-table drugs

Send your written response to the Office of Compounding Quality and Compliance (OCQC) within the Center for Drug Evaluation and Research (CDER)'s Office of Compliance at [email protected] within fifteen (15) working days of receipt of this letter.

Addressing any other website claims that contain false or misleading representations about the compounded drug products you offer for sale or demonstrating that such claims have been removed or revised such that they are no longer false or misleading within the meaning of FD&C Act §§ 502(a) and 502(bb) [21 U.S.C. §§ 352(a) and 352(bb)].

Identifying the entities that produce the compounded drug products offered on your website;

Providing a representative sample of labeling for such drug products;

You are advised to reassess your advertisements and promotional materials across all platforms, including television and social media.

Does your site contain similar claims?

The free site audit scans your whole site against every entry in this Atlas. Most glp-1 / weight loss sites match 3-6 patterns.

Run my free site audit

Want this watched for you? Free monthly monitoring re-scans your site against the Atlas ruleset and emails you when new flagged wording appears, and your site gets the "Compliance Monitored" seal. Start free monitoring.

Worried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.

Check specific copy in the Claim Checker